Tada A, Minami T, Kitai H, Higashiguchi Y, et al. Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation. Lung Cancer 2023;180:107219.
PMID: 37146474